[Retracted] Risk Factors and Prognostic Analysis of Gastrointestinal Stromal Tumor Recurrence-Metastasis

Table 2

Baseline data of patients.

Item	Category	n (%)
Gender	Male	199 (47.2%)
	Female	223 (52.8%)
Age (year)		25-82 (median: 60)
	<60	205
	≥60	217
Smoking history	Yes	84
	No	338
Drinking history	Yes	86
	No	336
Body mass index	<18.5	14
	18.5–23.9	167
	>23.9	167
	Not detected	74
Accompanied by malignant tumors #	Yes	76
	No	346
Primary location of tumor	Stomach	298 (70.9%)
	Small intestine	93 (22.1%)
	Other locations	29 (6.9%)
	Multiple primaries	2 (0.5%)
Pathological results	≤5 per 50 HPFs	337
	> 10 per 50 HPFs	29
	Not detected	56
Tumor diameter		0.2–23 cm (median: 4 cm)
Immunohistochemical results	CD117-positive	93.4% (394/422)
	CD34-positive	90.8% (383/422)
	DOG-1-positive	93.1% (393/422)
	Ki-67-positive	81.75% (345/422)
Other parameters	S-100	5.7%(24/422)
	SMA	19.4%(82/422)
Risk stratification	Very low	152
	Low	119
	Intermediate	44
	High	107
Treatment method	Laparotomy	161
	Laparoscopic resection	133
	Endoscopic resection	128
Follow up results	Recurrence	5
	Metastasis	24
	Recurrence and metastasis	7
	No recurrence or metastasis	386

Note: # accompanied by malignant tumors such as gastric adenocarcinoma, primary malignant tumor of liver, and colorectal malignant tumor.